Memorial Sloan Kettering Cancer Center

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8 (2022) Walle T, Kraske JA, Liao B, Lenoir B, Timke C, Halbach EVBU, Tran F, et al. Journal article Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies (2022) Cohen AD, Parekh S, Santomasso BD, Gallego Perez-Larraya J, Van De Donk NWCJ, Arnulf B, Mateos MV, et al. Journal article CellRank for directed single-cell fate mapping (2022) Lange M, Bergen V, Klein M, Setty M, Reuter B, Bakhti M, Lickert H, et al. Journal article The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. (2022) Netto GJ, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, et al. Journal article, Review article Virtual Mouse Brain Histology from Multi-contrast MRI via Deep Learning (2022) Liang Z, Lee CH, Arefin TM, Dong Z, Walczak P, Shi SH, Knoll F, et al. Journal article Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification (2022) Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, et al. Journal article Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. (2022) Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, Mccluggage WG, Pöschke P, et al. Journal article Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck (2022) Agaimy A, Dermawan JK, Leong I, Stöhr R, Swanson D, Weinreb I, Zhang L, et al. Journal article The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours (2022) Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, et al. Journal article, Review article Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. (2022) Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FY, et al. Journal article